Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 533543 | NSE: BROOKS

Watchlist

NSE BSE

159.99

20-Dec-2024

Open
High
Low
Previous Close

159.99
159.99
159.99
156.86

Volume
Traded Value (lacs)
52 Week High
52 Week Low

6112
9.78
185.70
73.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

434.38
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

440.75
N/A
7.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.69
2.67
-4.47

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-7.61
-
10.23

PAT CAGR (%)

10 Years
5 Years
3 Years

-16.66
-
20.17

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

3.57
3.57
3.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.56
14.56
10.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 20.79 24.32 -14.51% 17.93 15.70 14.20% 17.72 12.61 40.52% 21.75 12.00 81.25%
Expenses 19.28 22.60 -14.69% 17.65 15.68 12.56% 17.34 12.73 36.21% 20.65 13.47 53.30%
EBITDA 1.51 1.72 -12.21% 0.28 0.02 1,300.00% 0.38 -0.12 - 1.10 -1.47 -
EBIDTM 7.26% 7.06% 1.57% 0.16% 2.14% -0.95% 5.04% -12.26%
Other Income 0.20 0.09 122.22% 0.07 0.06 16.67% 0.65 0.03 2,066.67% 0.16 0.06 166.67%
Interest 0.32 0.19 68.42% 0.16 0.17 -5.88% 0.27 0.18 50.00% 0.21 0.24 -12.50%
Depreciation 0.43 0.44 -2.27% 0.40 0.44 -9.09% 0.46 0.43 6.98% 0.43 0.43 0.00%
PBT 0.96 1.18 -18.64% -0.21 -0.53 - 0.30 -0.71 - 0.60 -2.08 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.03 0.00 0
PAT 0.96 1.18 -18.64% -0.21 -0.53 - 0.30 -0.71 - 0.58 -2.08 -
PATM 4.59% 4.85% -1.18% -3.39% 1.72% -5.64% 2.65% -17.34%
EPS 0.36 0.45 -20.00% -0.08 -0.20 - 0.12 -0.27 - 0.22 -0.79 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 20.79 24.32 -14.51% 17.93 15.70 14.20% 17.72 12.61 40.52% 21.75 15.30 42.16%
Expenses 19.28 22.60 -14.69% 17.65 15.68 12.56% 17.34 12.73 36.21% 20.65 23.86 -13.45%
EBITDA 1.51 1.72 -12.21% 0.28 0.02 1,300.00% 0.38 -0.12 - 1.10 -8.55 -
EBIDTM 7.26% 7.06% 1.57% 0.16% 2.14% -0.95% 5.04% -55.90%
Other Income 0.20 0.09 122.22% 0.07 0.06 16.67% 0.65 0.03 2,066.67% 0.16 0.09 77.78%
Interest 0.32 0.19 68.42% 0.16 0.17 -5.88% 0.27 0.18 50.00% 0.21 0.75 -72.00%
Depreciation 0.43 0.44 -2.27% 0.40 0.44 -9.09% 0.46 0.43 6.98% 0.43 2.33 -81.55%
PBT 0.96 1.18 -18.64% -0.21 -0.53 - 0.30 -0.71 - 0.60 -11.18 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.03 -1.70 -
PAT 0.96 1.18 -18.64% -0.21 -0.53 - 0.30 -0.71 - 0.58 -9.48 -
PATM 4.59% 4.85% -1.18% -3.39% 1.72% -5.64% 2.65% -61.98%
EPS -1.51 -0.62 - -0.92 -1.79 - -3.66 -1.72 - -1.48 -2.01 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 78.19 79.49 55.54 76.97 77.27 69.69 55.03 55.71 57.54 80.01 85.21 Net Sales Growth 20.98% 43.12% -27.84% -0.39% 10.88% 26.64% -1.22% -3.18% -28.08% -6.10% Cost Of Goods Sold 53.68 56.62 40.46 49.27 47.77 46.84 39.43 39.38 36.66 52.95 60.65 Gross Profit 24.51 22.87 15.08 27.69 29.50 22.85 15.59 16.34 20.88 27.07 24.57 GP Margin 31.35% 28.77% 27.15% 35.98% 38.18% 32.79% 28.33% 29.33% 36.29% 33.83% 28.83% Total Expenditure 74.92 76.43 61.35 75.09 76.33 73.61 63.39 64.64 52.50 68.93 78.46 Power & Fuel Cost - 1.73 1.58 1.64 2.70 2.90 2.56 3.62 1.54 2.05 2.62 % Of Sales - 2.18% 2.84% 2.13% 3.49% 4.16% 4.65% 6.50% 2.68% 2.56% 3.07% Employee Cost - 10.09 10.65 10.88 12.04 11.16 10.04 9.65 6.16 5.20 3.75 % Of Sales - 12.69% 19.18% 14.14% 15.58% 16.01% 18.24% 17.32% 10.71% 6.50% 4.40% Manufacturing Exp. - 3.04 2.54 5.38 4.85 3.95 3.59 3.88 1.69 2.12 2.27 % Of Sales - 3.82% 4.57% 6.99% 6.28% 5.67% 6.52% 6.96% 2.94% 2.65% 2.66% General & Admin Exp. - 2.74 3.11 4.48 4.18 4.73 3.99 4.46 3.24 3.03 2.48 % Of Sales - 3.45% 5.60% 5.82% 5.41% 6.79% 7.25% 8.01% 5.63% 3.79% 2.91% Selling & Distn. Exp. - 0.99 1.52 1.68 1.54 0.95 0.73 1.03 1.82 2.05 4.89 % Of Sales - 1.25% 2.74% 2.18% 1.99% 1.36% 1.33% 1.85% 3.16% 2.56% 5.74% Miscellaneous Exp. - 1.23 1.50 1.75 3.24 3.08 3.05 2.61 1.39 1.54 4.89 % Of Sales - 1.55% 2.70% 2.27% 4.19% 4.42% 5.54% 4.68% 2.42% 1.92% 2.12% EBITDA 3.27 3.06 -5.81 1.88 0.94 -3.92 -8.36 -8.93 5.04 11.08 6.75 EBITDA Margin 4.18% 3.85% -10.46% 2.44% 1.22% -5.62% -15.19% -16.03% 8.76% 13.85% 7.92% Other Income 1.08 1.11 0.12 0.95 0.96 0.41 2.88 0.24 0.12 1.56 2.36 Interest 0.96 0.84 0.77 0.67 3.25 3.35 2.96 2.40 1.01 0.79 0.44 Depreciation 1.72 1.77 1.72 1.49 7.09 6.65 6.50 6.45 1.67 1.16 1.10 PBT 1.65 1.55 -8.18 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 7.57 Tax 0.03 0.03 0.00 0.00 7.15 10.86 -0.14 -3.72 0.82 0.19 0.88 Tax Rate 1.82% 1.94% 0.00% 0.00% -84.72% -80.38% 0.94% 21.22% 33.06% 1.76% 8.50% PAT 1.63 1.53 -8.18 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 9.47 PAT before Minority Interest 1.63 1.53 -8.18 0.67 -15.59 -24.38 -14.81 -13.81 1.67 10.63 9.47 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.08% 1.92% -14.73% 0.87% -20.18% -34.98% -26.91% -24.79% 2.90% 13.29% 11.11% PAT Growth 176.17% - - - - - - - -84.29% 12.25% EPS 0.62 0.58 -3.12 0.26 -5.95 -9.31 -5.65 -5.27 0.64 4.06 3.61

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 78.19 79.49 63.20 91.18 77.25 Net Sales Growth 15.10% 25.78% -30.69% 18.03% Cost Of Goods Sold 53.68 56.62 50.60 62.79 47.57 Gross Profit 24.51 22.87 12.60 28.40 29.67 GP Margin 31.35% 28.77% 19.94% 31.15% 38.41% Total Expenditure 74.92 76.43 89.62 105.44 76.73 Power & Fuel Cost - 1.73 3.23 3.99 2.70 % Of Sales - 2.18% 5.11% 4.38% 3.50% Employee Cost - 10.09 16.00 16.85 12.04 % Of Sales - 12.69% 25.32% 18.48% 15.59% Manufacturing Exp. - 3.04 7.85 9.53 5.44 % Of Sales - 3.82% 12.42% 10.45% 7.04% General & Admin Exp. - 2.74 5.42 6.37 4.19 % Of Sales - 3.45% 8.58% 6.99% 5.42% Selling & Distn. Exp. - 0.99 1.68 1.69 1.54 % Of Sales - 1.25% 2.66% 1.85% 1.99% Miscellaneous Exp. - 1.23 4.84 4.22 3.23 % Of Sales - 1.55% 7.66% 4.63% 4.18% EBITDA 3.27 3.06 -26.42 -14.26 0.52 EBITDA Margin 4.18% 3.85% -41.80% -15.64% 0.67% Other Income 1.08 1.11 0.21 0.80 0.74 Interest 0.96 0.84 2.18 3.10 3.10 Depreciation 1.72 1.77 7.03 7.35 7.14 PBT 1.65 1.55 -35.42 -23.90 -8.99 Tax 0.03 0.03 -7.32 -4.59 10.38 Tax Rate 1.82% 1.94% 20.88% 19.21% -115.46% PAT 1.63 -19.59 -20.90 -11.29 -19.38 PAT before Minority Interest 1.63 -19.59 -31.05 -19.31 -19.38 Minority Interest 0.00 0.00 10.15 8.02 0.00 PAT Margin 2.08% -24.64% -33.07% -12.38% -25.09% PAT Growth 117.09% - - - EPS 0.62 -7.48 -7.98 -4.31 -7.40

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 69.53 56.78 65.00 64.21 98.42 105.15 114.47 128.28 122.05 111.42 Share Capital 26.25 24.70 24.70 24.70 24.70 16.19 16.19 16.19 16.19 16.19 Total Reserves 43.28 32.08 40.30 39.51 73.71 83.41 98.29 112.09 105.86 95.23 Non-Current Liabilities 1.81 2.62 2.99 3.10 13.65 4.43 6.97 5.24 6.14 1.99 Secured Loans 0.00 0.00 0.00 1.34 11.40 13.86 16.63 10.73 0.34 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.93 1.46 1.65 1.54 1.72 1.48 1.08 1.51 4.34 0.66 Current Liabilities 23.05 33.02 35.46 25.69 45.80 47.39 40.48 24.26 27.92 22.14 Trade Payables 15.44 23.37 25.75 13.39 26.07 27.14 26.65 18.36 15.72 19.04 Other Current Liabilities 1.92 2.67 4.07 4.86 6.56 5.34 4.95 3.60 5.61 1.80 Short Term Borrowings 5.04 5.66 4.91 6.82 12.61 14.47 8.54 2.18 5.28 0.51 Short Term Provisions 0.64 1.32 0.74 0.63 0.56 0.44 0.35 0.13 1.31 0.78 Total Liabilities 94.39 92.42 103.45 93.00 157.87 156.97 161.92 157.78 156.11 135.55 Net Block 13.67 15.01 15.14 14.96 113.02 117.25 124.01 125.31 16.34 15.68 Gross Block 23.27 22.83 21.07 19.64 132.51 131.80 132.11 126.99 23.02 21.34 Accumulated Depreciation 9.60 7.83 5.93 4.68 19.49 14.54 8.10 1.67 6.68 5.65 Non Current Assets 63.34 64.82 66.42 65.13 119.95 125.23 131.23 135.91 126.18 80.76 Capital Work in Progress 0.00 0.00 1.12 0.02 0.11 0.29 0.52 0.00 86.86 52.86 Non Current Investment 46.86 46.85 46.84 46.81 0.02 0.47 0.65 0.65 0.02 0.02 Long Term Loans & Adv. 2.68 2.79 3.10 3.04 6.68 7.04 5.93 9.95 22.96 12.20 Other Non Current Assets 0.13 0.17 0.22 0.31 0.11 0.18 0.12 0.00 0.00 0.00 Current Assets 31.05 27.61 37.04 25.34 37.92 31.74 30.70 21.87 29.94 54.78 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.61 11.30 16.59 12.38 13.77 10.05 11.41 7.70 6.69 7.53 Sundry Debtors 16.32 12.75 15.03 9.59 15.56 11.42 10.18 10.69 18.91 19.29 Cash & Bank 0.69 1.08 1.08 0.88 1.53 3.32 1.96 1.84 2.23 22.92 Other Current Assets 4.43 0.40 1.41 0.61 7.06 6.95 7.13 1.65 2.11 5.03 Short Term Loans & Adv. 2.57 2.08 2.93 1.88 0.64 0.54 0.45 0.88 1.89 0.30 Net Current Assets 8.00 -5.42 1.57 -0.34 -7.88 -15.65 -9.79 -2.39 2.02 32.64 Total Assets 94.39 92.43 103.46 90.47 157.87 156.97 161.93 157.78 156.12 135.54

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 65.59 73.95 87.49 79.15 Share Capital 26.25 24.70 24.70 24.70 Total Reserves 39.34 49.25 62.79 54.45 Non-Current Liabilities 1.81 2.62 11.36 19.31 Secured Loans 0.00 0.00 9.29 14.44 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.93 1.46 2.17 1.54 Current Liabilities 23.05 33.02 48.88 63.61 Trade Payables 15.44 23.37 28.00 30.95 Other Current Liabilities 1.92 2.67 8.80 17.89 Short Term Borrowings 5.04 5.66 11.05 13.64 Short Term Provisions 0.64 1.32 1.03 1.13 Total Liabilities 90.45 109.59 194.56 162.07 Net Block 13.67 15.01 110.01 107.56 Gross Block 23.27 22.83 142.81 133.42 Accumulated Depreciation 9.60 7.83 32.79 25.86 Non Current Assets 59.40 81.99 133.37 112.19 Capital Work in Progress 0.00 0.00 15.11 0.83 Non Current Investment 42.91 64.03 0.06 0.02 Long Term Loans & Adv. 2.68 2.79 7.97 3.48 Other Non Current Assets 0.13 0.17 0.22 0.31 Current Assets 31.05 27.61 61.18 47.36 Current Investments 0.00 0.00 0.00 0.00 Inventories 9.61 11.30 27.52 23.60 Sundry Debtors 16.32 12.75 17.66 13.70 Cash & Bank 0.69 1.08 3.81 1.70 Other Current Assets 4.43 0.40 1.55 0.65 Short Term Loans & Adv. 2.57 2.08 10.64 7.70 Net Current Assets 8.00 -5.42 12.30 -16.25 Total Assets 90.45 109.60 194.55 159.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -9.68 0.55 3.12 -0.90 -9.39 -5.04 -6.18 9.56 8.12 2.13 PBT 1.55 -8.18 0.67 -8.44 -13.51 -14.95 -17.53 2.48 10.69 7.57 Adjustment 1.64 2.76 2.43 10.23 11.76 9.24 9.83 3.26 0.67 -0.66 Changes in Working Capital -13.07 6.17 0.29 1.51 -7.62 1.22 2.31 5.55 2.15 -3.98 Cash after chg. in Working capital -9.88 0.74 3.39 3.30 -9.38 -4.48 -5.40 11.29 13.51 2.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.20 -0.19 -0.26 -4.20 -0.01 -0.56 -0.78 -1.73 -5.39 -1.66 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.87 Cash From Investing Activity 0.18 -0.40 1.12 -0.74 -2.33 1.12 -5.14 -16.80 -13.56 -1.12 Net Fixed Assets -0.44 -0.64 -2.53 112.96 -0.53 0.54 -5.64 -17.11 -35.68 -12.37 Net Investments -0.01 -0.01 -0.03 -46.79 0.45 0.18 0.00 -0.63 0.00 0.00 Others 0.63 0.25 3.68 -66.91 -2.25 0.40 0.50 0.94 22.12 11.25 Cash from Financing Activity 9.60 -0.21 -4.22 1.31 9.61 5.78 11.82 7.01 4.32 -0.07 Net Cash Inflow / Outflow 0.10 -0.06 0.02 -0.33 -2.10 1.85 0.51 -0.23 -1.12 0.94 Opening Cash & Equivalents 0.02 0.08 0.06 0.40 2.50 0.65 0.14 0.37 1.49 0.55 Closing Cash & Equivalent 0.13 0.02 0.08 0.06 0.40 2.50 0.65 0.14 0.37 1.49

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity -9.68 -14.49 -37.44 4.46 PBT -19.57 -38.37 -23.90 -8.99 Adjustment 22.76 12.61 11.05 10.29 Changes in Working Capital -13.07 11.43 -24.33 7.37 Cash after chg. in Working capital -9.88 -14.34 -37.18 8.66 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid 0.20 -0.15 -0.26 -4.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.18 0.49 -24.91 -5.13 Net Fixed Assets -0.44 -0.64 -2.53 Net Investments -0.01 -0.01 -0.03 Others 0.63 1.14 -22.35 Cash from Financing Activity 9.60 11.41 64.07 1.16 Net Cash Inflow / Outflow 0.10 -2.58 1.72 0.49 Opening Cash & Equivalents 0.02 2.61 0.88 0.40 Closing Cash & Equivalent 0.13 0.02 2.61 0.88

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 26.49 22.76 26.06 25.99 39.84 51.31 58.97 66.08 62.87 57.40 ROA 1.64% -8.36% 0.68% -12.43% -15.48% -9.29% -8.64% 1.06% 7.29% 7.06% ROE 2.42% -13.44% 1.03% -19.17% -24.62% -13.83% -11.38% 1.33% 9.11% 8.59% ROCE 3.50% -11.21% 1.87% -5.24% -7.77% -8.60% -10.64% 2.59% 9.69% 9.76% Fixed Asset Turnover 3.45 2.53 3.78 1.02 0.53 0.42 0.44 0.86 3.61 3.70 Receivable days 66.75 91.32 58.39 59.40 70.66 71.64 66.94 83.32 87.15 76.58 Inventory Days 48.02 91.65 68.68 61.77 62.40 71.18 61.28 40.49 32.44 29.05 Payable days 125.11 221.56 144.92 150.71 126.49 149.31 121.22 121.35 94.73 84.10 Cash Conversion Cycle -10.34 -38.60 -17.85 -29.54 6.57 -6.50 7.00 2.46 24.87 21.53 Total Debt/Equity 0.07 0.10 0.08 0.13 0.27 0.31 0.24 0.11 0.05 0.00 Interest Cover 2.84 -9.67 1.99 -1.60 -3.03 -4.05 -6.29 3.46 14.62 24.34

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 24.99 29.65 35.07 32.04 ROA -19.59% -20.41% -10.83% -11.95% ROE -28.08% -38.46% -23.18% -24.48% ROCE -24.92% -37.83% -18.72% -5.33% Fixed Asset Turnover 3.45 0.76 0.66 0.58 Receivable days 66.75 87.83 62.77 64.72 Inventory Days 48.02 112.11 102.32 111.53 Payable days 125.11 185.27 171.35 237.48 Cash Conversion Cycle -10.34 14.66 -6.26 -61.23 Total Debt/Equity 0.08 0.08 0.28 0.40 Interest Cover -22.16 -16.58 -6.72 -1.90

Top Investors:

quant mutual fund-quant business cycle fund

Annual Reports:

News Update:

Brooks Laboratories - Quarterly Results
9th Nov 2024, 16:36 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback